Total raised
—
Last: Seed 2023-12
Stage
Seed
Founded
2021
Headcount
8
HQ
Yavne
Sector
Health Tech & Life Sciences
About
Trojan Bio is a preclinical immunotherapy company developing a novel class of therapeutic antibodies for the treatment of a variety of cancers. The company’s Trojan antibodies integrate viral peptides to efficiently activate the immune system for cancer eradication.
Trojan Bio specific antibody is composed of 2 modules - Cancer targeting module and a Viral immunity activation module. It targets cancer cells and label them as virally infected cells. The company is harnessing the powerful anti-viral immunity to fight a variety of cancers.
Funding history · 2 rounds · — total
2023-12
Seed
Undisclosed
2022-09
Pre-Seed
Undisclosed
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 Patents
Tags
cancerclinicspharmaceuticalsimmuno-theraphycancer-therapy